Nathalie Scholler Penn Ovarian Cancer Research Center, Center for Research on Reproduction and Womans Health, Department of Obstetrics and Gynecology University of Pennsylvania-School of Medicine Biography Publications Institution JoVE Articles Nathalie Scholler has not added a biography. If you are Nathalie Scholler and would like to personalize this page please email our Author Liaison for assistance. Publications A Universal Strategy for Adoptive Immunotherapy of Cancer Through Use of a Novel T Cell Antigen Receptor Cancer Research. Feb, 2012 | Pubmed ID: 22315351 Oncology Biomarkers for Gynecologic Malignancies Frontiers in Bioscience (Elite Edition). 2012 | Pubmed ID: 22201939 Correlation of Serum HE4 with Tumor Size and Myometrial Invasion in Endometrial Cancer Gynecologic Oncology. Feb, 2012 | Pubmed ID: 22037318 Mannose Receptor (MR) Engagement by Mesothelin GPI Anchor Polarizes Tumor-associated Macrophages and is Blocked by Anti-MR Human Recombinant Antibody PloS One. 2011 | Pubmed ID: 22163010 Redirected Antitumor Activity of Primary Human Lymphocytes Transduced With a Fully Human Anti-mesothelin Chimeric Receptor Molecular Therapy : the Journal of the American Society of Gene Therapy. Nov, 2011 | Pubmed ID: 22127019 Potential Role of HE4 in Multimodal Screening for Epithelial Ovarian Cancer Journal of the National Cancer Institute. Nov, 2011 | Pubmed ID: 21917606 Novel Surface Targets and Serum Biomarkers from the Ovarian Cancer Vasculature Cancer Biology & Therapy. Aug, 2011 | Pubmed ID: 21617380 A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer Cancer Prevention Research (Philadelphia, Pa.). Mar, 2011 | Pubmed ID: 21372037 Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens Cancer Prevention Research (Philadelphia, Pa.). Mar, 2011 | Pubmed ID: 21372036 Rapid Isolation of High-affinity Human Antibodies Against the Tumor Vascular Marker Endosialin/TEM1, Using a Paired Yeast-display/secretory ScFv Library Platform Journal of Immunological Methods. Jan, 2011 | Pubmed ID: 20837020 Assessing Lead Time of Selected Ovarian Cancer Biomarkers: a Nested Case-control Study Journal of the National Cancer Institute. Jan, 2010 | Pubmed ID: 20042715 Use of a Symptom Index, CA125, and HE4 to Predict Ovarian Cancer Gynecologic Oncology. Mar, 2010 | Pubmed ID: 19945742 Antifouling Surface Layers for Improved Signal-to-noise of Particle-based Immunoassays Langmuir : the ACS Journal of Surfaces and Colloids. Dec, 2009 | Pubmed ID: 19928944 Beyond CA125: the Coming of Age of Ovarian Cancer Biomarkers. Are We There Yet? Biomarkers in Medicine. Jun, 2009 | Pubmed ID: 19684876 Influence of Ovarian Cancer Risk Status on the Diagnostic Performance of the Serum Biomarkers Mesothelin, HE4, and CA125 Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. May, 2009 | Pubmed ID: 19423517 Oncology Biomarkers--second Annual GTCbio Conference. Biomarkers for Disease Detection and Therapeutics Monitoring. 19-20 January 2009, Miami, FL, USA IDrugs : the Investigational Drugs Journal. Apr, 2009 | Pubmed ID: 19350459 Maternal Mortality from Systemic Illness: Unraveling the Contribution of the Immune Response American Journal of Obstetrics and Gynecology. Apr, 2009 | Pubmed ID: 19318152 Effects of Personal Characteristics on Serum CA125, Mesothelin, and HE4 Levels in Healthy Postmenopausal Women at High-risk for Ovarian Cancer Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. Sep, 2008 | Pubmed ID: 18768519 Use of Cancer-specific Yeast-secreted in Vivo Biotinylated Recombinant Antibodies for Serum Biomarker Discovery Journal of Translational Medicine. 2008 | Pubmed ID: 18652693 Combining a Symptoms Index with CA 125 to Improve Detection of Ovarian Cancer Cancer. Aug, 2008 | Pubmed ID: 18615684 Systematic Evaluation of Candidate Blood Markers for Detecting Ovarian Cancer PloS One. 2008 | Pubmed ID: 18612378 A Mouse to Human Search for Plasma Proteome Changes Associated with Pancreatic Tumor Development PLoS Medicine. Jun, 2008 | Pubmed ID: 18547137 Use of Yeast-secreted in Vivo Biotinylated Recombinant Antibodies (Biobodies) in Bead-based ELISA Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. May, 2008 | Pubmed ID: 18451228 CA125 in Ovarian Cancer Biomarkers in Medicine. Dec, 2007 | Pubmed ID: 20477371 Use of High Density Antibody Arrays to Validate and Discover Cancer Serum Biomarkers Molecular Oncology. Dec, 2007 | Pubmed ID: 19383305 Development and in Vitro Validation of Anti-mesothelin Biobodies That Prevent CA125/Mesothelin-dependent Cell Attachment Cancer Letters. Oct, 2007 | Pubmed ID: 17560019 Development of a CA125-mesothelin Cell Adhesion Assay As a Screening Tool for Biologics Discovery Cancer Letters. Mar, 2007 | Pubmed ID: 16677756 Method for Generation of in Vivo Biotinylated Recombinant Antibodies by Yeast Mating Journal of Immunological Methods. Dec, 2006 | Pubmed ID: 17113097 Bead-based ELISA for Validation of Ovarian Cancer Early Detection Markers Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Apr, 2006 | Pubmed ID: 16609024 Plasmid-based Vaccines Encoding Rat Neu and Immune Stimulatory Molecules Can Elicit Rat Neu-specific Immunity Molecular Cancer Therapeutics. Oct, 2003 | Pubmed ID: 14578464 Cutting Edge: CD83 Regulates the Development of Cellular Immunity Journal of Immunology (Baltimore, Md. : 1950). Mar, 2002 | Pubmed ID: 11884422 Ортотопическая Модель серозного рака яичников у иммунокомпетентных мышей для В естественных условиях Опухоль изображений и мониторинг иммунного ответа опухоли Selene Nunez-Cruz1, Denise C. Connolly2, Nathalie Scholler1 1Penn Ovarian Cancer Research Center, Center for Research on Reproduction and Womans Health, Department of Obstetrics and Gynecology, University of Pennsylvania-School of Medicine, 2Women's Cancer Program, Fox Chase Cancer Center JoVE 2146 Immunology and Infection
Ортотопическая Модель серозного рака яичников у иммунокомпетентных мышей для В естественных условиях Опухоль изображений и мониторинг иммунного ответа опухоли Selene Nunez-Cruz1, Denise C. Connolly2, Nathalie Scholler1 1Penn Ovarian Cancer Research Center, Center for Research on Reproduction and Womans Health, Department of Obstetrics and Gynecology, University of Pennsylvania-School of Medicine, 2Women's Cancer Program, Fox Chase Cancer Center JoVE 2146 Immunology and Infection